The General Meeting of 15 June Approved a Number of Changes to the Articles of Association, Including the Creation of a Mission Committee, the Adoption of a New Corporate Purpose, and a New Corporate Name for the European Company, Clariane

Regulatory News:

The Annual General Meeting of shareholders of Korian, now Clariane (Paris:KORI), was held on 15 June 2023. It was chaired by Jean-Pierre Duprieu, Chairman of the Board of Directors, and was attended by Sophie Boissard, Group Chief Executive Officer, Philippe Garin, Group Chief Financial Officer, Amandine Daviet, Group General Secretary, the members of the Board of Directors and the Statutory Auditors.

• Adoption of a new corporate purpose and conversion into a purpose-driven company

The General Meeting approved the adoption of a new corporate purpose for the Group: “To take care of each person’s humanity in times of vulnerability”.
This corporate purpose is the product of extensive consultation with all our employees and stakeholders and is inspired by the Group’s three core values: trust, responsibility and initiative.

The General Meeting approved the conversion to a purpose-driven company, within the meaning of Article L 210-10 of the French Commercial Code. This status as a purpose-driven company is manifested by five commitments to residents, patients and their family carers, as well as to employees and local communities, focused on the themes of consideration, equity, innovation, proximity and sustainability.

The Group will launch ten initial concrete initiatives based on these commitments (see appendices), including the launch of Clariane University on 4 July 2023. Each year, this new corporate university will provide at least 6,500 employees with the opportunity to take qualifying training courses, ranging from vocational certificates to university degrees, in the Group’s main professional fields (care and health, catering and hospitality, management, human resources and finance).

The General Meeting approved the creation of a mission committee, made up of representatives of patients and residents, employees and qualified personalities.
Its role will be to monitor the implementation of the initiatives undertaken, with the support of an independent third-party organisation. It will serve as a forum providing all stakeholders in the governance process with the opportunity to be heard over the long term, and will present a report each year at future annual general meetings, which will be made public.